Concepedia

M. de Jong

MD

10

Publications

683

Citations

10

H-Index

1963

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

University of Bern

Erasmus University Rotterdam

Mallinckrodt (United States)

Erasmus MC

M. de Jong is an author at Rotterdam University of Applied Sciences specializing in medicine, pharmacology, and theranostics.

Top concepts

Publications per year

1963–2003

10

Publications

10

Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

M. de Jong, W A Breeman, WH Bakker et al. · PubMed · 1998 · 210 citations

, , +21

D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.

Bert F. Bernard, E. P. Krenning, Wout A. P. Breeman et al. · PubMed · 1997 · 146 citations

Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer

M. Visser, Paul J. J. M. Janssen, A. Srinivasan et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 100 citations

, , +8

Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.

M. de Jong, Willem H. Bakker, Bert F. Bernard et al. · PubMed · 1999 · 81 citations

ISO-enzyme patterns of serum alkaline phosphatase in agar-gel electrophoresis and their clinical significance

W. G. Haije, M. de Jong · Clinica Chimica Acta · 1963 · 71 citations

, , +13

Rows per page

1–5 of 10